论文部分内容阅读
目的探讨肝脏转移瘤的微创治疗方法及疗效评价。方法收集行微创治疗的肝脏转移瘤42例患者。行肝动脉化疗栓塞术35例,CT引导下射频消融术7例。结果介入及射频治疗后患者一般情况较术前均有明显改善。随访结果,患者生存期6个月92.85%、1年73.80%、2年54.67%,目前存活3年以上3例。结论对于肝转移瘤给予相应的微创治疗,患者的生存期及生存质量都有显著提高。
Objective To investigate the minimally invasive treatment of liver metastases and evaluate the therapeutic effect. Methods We collected 42 patients with minimally invasive liver metastases. 35 cases underwent transcatheter arterial chemoembolization and 7 cases underwent radiofrequency catheter ablation guided by CT. Results After intervention and radiofrequency ablation, the general condition of patients was significantly improved compared with that before operation. Follow-up results, patients with survival of 92.85 months 6 months, 73.8% for 1 year, 54.67% for 2 years, currently 3 years survived more than 3 cases. Conclusion For minimally invasive treatment of liver metastases, the patients’ life span and quality of life are significantly improved.